139 related articles for article (PubMed ID: 2235195)
1. Catheter-related sepsis refractory to antibiotics treated successfully with adjunctive urokinase infusion.
Fishbein JD; Friedman HS; Bennett BB; Falletta JM
Pediatr Infect Dis J; 1990 Sep; 9(9):676-8. PubMed ID: 2235195
[No Abstract] [Full Text] [Related]
2. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
[TBL] [Abstract][Full Text] [Related]
3. Urokinase therapy in neonates with catheter related central venous thrombosis.
Wever ML; Liem KD; Geven WB; Tanke RB
Thromb Haemost; 1995 Feb; 73(2):180-5. PubMed ID: 7792727
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients.
Jones GR; Konsler GK; Dunaway RP; Lacey SR; Azizkhan RG
J Pediatr Surg; 1993 Mar; 28(3):350-5; discussion 355-7. PubMed ID: 8468645
[TBL] [Abstract][Full Text] [Related]
5. Prevention of indwelling central venous catheter sepsis.
Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of superior vena cava syndrome with urokinase in an infant with a central venous catheter.
Caglar MK; Tolboom J
Helv Paediatr Acta; 1989 Jun; 43(5-6):483-6. PubMed ID: 2501237
[TBL] [Abstract][Full Text] [Related]
7. Urokinase administration in pediatric patients with occluded central venous catheters.
Wachs T
J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
[TBL] [Abstract][Full Text] [Related]
8. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
9. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
Bagnall HA; Gomperts E; Atkinson JB
Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
[TBL] [Abstract][Full Text] [Related]
10. Intravenous catheter-related infections.
Salzman MB; Rubin LG
Adv Pediatr Infect Dis; 1995; 10():337-68. PubMed ID: 7718211
[TBL] [Abstract][Full Text] [Related]
11. Removal of percutaneously inserted central venous catheters in neonates is associated with the occurrence of sepsis.
van den Hoogen A; Brouwer MJ; Gerards LJ; Fleer A; Krediet TG
Acta Paediatr; 2008 Sep; 97(9):1250-2. PubMed ID: 18477060
[TBL] [Abstract][Full Text] [Related]
12. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
13. Tunneled central venous catheter complications and the iatrogenic superior vena cava syndrome.
Presant CA
N Y State J Med; 1992 Feb; 92(2):43-4. PubMed ID: 1565309
[No Abstract] [Full Text] [Related]
14. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
De Sio L; Jenkner A; Milano GM; Ilari I; Fidani P; Castellano A; Gareri R; Donfrancesco A
Pediatr Infect Dis J; 2004 Oct; 23(10):963-5. PubMed ID: 15602201
[TBL] [Abstract][Full Text] [Related]
15. [Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter].
Garaventa A; Castagnola E; Dallorso S; Dini G; Trucco D; Vianello O; Carrega G; Cuneo P; Buffa P; Magillo P
Pediatr Med Chir; 1995; 17(2):147-50. PubMed ID: 7610079
[TBL] [Abstract][Full Text] [Related]
16. Management of septic complications associated with Silastic catheters in childhood malignancy.
Hartman GE; Shochat SJ
Pediatr Infect Dis J; 1987 Nov; 6(11):1042-7. PubMed ID: 3696842
[TBL] [Abstract][Full Text] [Related]
17. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
18. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
van Rooden CJ; Schippers EF; Guiot HF; Barge RM; Hovens MM; van der Meer FJ; Rosendaal FR; Huisman MV
J Clin Oncol; 2008 Jan; 26(3):428-33. PubMed ID: 18202420
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis.
Atkinson JB; Chamberlin K; Boody BA
J Pediatr Surg; 1998 May; 33(5):714-6. PubMed ID: 9607475
[TBL] [Abstract][Full Text] [Related]
20. Difficulty in removing a percutaneous central venous catheter inserted from a peripheral vein.
Morimoto T; Hosoya R; Matsufuji H; Tachi M; Yokoyama J; Nishimura K
Acta Paediatr Jpn; 1993 Aug; 35(4):352-3. PubMed ID: 8379329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
